Ferulic Acid Attenuates Aortic Stiffening and Cardiovascular Remodeling by Suppressing Inflammation and the Renin-Angiotensin System in Rats Fed a High-Fat/High-Carbohydrate Diet.
Ketmanee Senaphan, Weerapon Sangartit, Veerapol Kukongviriyapan, Orachorn Boonla, Stephen E Greenwald, Upa Kukongviriyapan
{"title":"Ferulic Acid Attenuates Aortic Stiffening and Cardiovascular Remodeling by Suppressing Inflammation and the Renin-Angiotensin System in Rats Fed a High-Fat/High-Carbohydrate Diet.","authors":"Ketmanee Senaphan, Weerapon Sangartit, Veerapol Kukongviriyapan, Orachorn Boonla, Stephen E Greenwald, Upa Kukongviriyapan","doi":"10.7570/jomes24017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ferulic acid (FA) is an antioxidant compound present in cereals, fruits, and vegetables. Chronic consumption of a high-fat and high-carbohydrate (HFHC) diet can lead to metabolic syndrome and increase the risk of atherosclerotic cardiovascular disease. This study examined whether FA could mitigate vascular inflammation, aortic stiffness, and cardiovascular remodeling in rats fed a HFHC diet.</p><p><strong>Methods: </strong>Male Sprague-Dawley rats were divided into five groups (eight rats/group): one group was fed a standard chow diet with or without FA supplementation, while the others were fed a HFHC diet plus a 15% fructose solution for 16 weeks. Rats on the HFHC diet received FA at doses of 0, 30, or 60 mg/kg/day during the final 6 weeks of the study. Various cardiovascular parameters, plasma biochemical markers, and the expression of biomarker proteins were measured.</p><p><strong>Results: </strong>FA administration alleviated the metabolic disturbances caused by the HFHC diet. FA reduced arterial blood pressure, aortic pulse wave velocity, oxidative stress, vascular inflammation, and angiotensin-mediated myocardial fibrosis and cardiac hypertrophy, as evidenced by decreases in ventricular interstitial fibrosis and cross-sectional area. These beneficial effects were associated with reduced vascular superoxide production and lower plasma levels of angiotensin-converting enzyme and tumor necrosis factor α. FA also suppressed the expression of Ang II type 1 receptor, gp91<sup>phox</sup>, and vascular-adhesion molecule 1 proteins and prevented hypertrophic remodeling of the aortic wall by reducing protein expression of matrix metalloproteinases 2 and 9.</p><p><strong>Conclusion: </strong>This study provides insightful findings on the beneficial effects of FA in reducing aortic stiffness and cardiovascular remodeling associated with metabolic syndrome.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":"291-302"},"PeriodicalIF":7.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity & Metabolic Syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7570/jomes24017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Ferulic acid (FA) is an antioxidant compound present in cereals, fruits, and vegetables. Chronic consumption of a high-fat and high-carbohydrate (HFHC) diet can lead to metabolic syndrome and increase the risk of atherosclerotic cardiovascular disease. This study examined whether FA could mitigate vascular inflammation, aortic stiffness, and cardiovascular remodeling in rats fed a HFHC diet.
Methods: Male Sprague-Dawley rats were divided into five groups (eight rats/group): one group was fed a standard chow diet with or without FA supplementation, while the others were fed a HFHC diet plus a 15% fructose solution for 16 weeks. Rats on the HFHC diet received FA at doses of 0, 30, or 60 mg/kg/day during the final 6 weeks of the study. Various cardiovascular parameters, plasma biochemical markers, and the expression of biomarker proteins were measured.
Results: FA administration alleviated the metabolic disturbances caused by the HFHC diet. FA reduced arterial blood pressure, aortic pulse wave velocity, oxidative stress, vascular inflammation, and angiotensin-mediated myocardial fibrosis and cardiac hypertrophy, as evidenced by decreases in ventricular interstitial fibrosis and cross-sectional area. These beneficial effects were associated with reduced vascular superoxide production and lower plasma levels of angiotensin-converting enzyme and tumor necrosis factor α. FA also suppressed the expression of Ang II type 1 receptor, gp91phox, and vascular-adhesion molecule 1 proteins and prevented hypertrophic remodeling of the aortic wall by reducing protein expression of matrix metalloproteinases 2 and 9.
Conclusion: This study provides insightful findings on the beneficial effects of FA in reducing aortic stiffness and cardiovascular remodeling associated with metabolic syndrome.
期刊介绍:
The journal was launched in 1992 and diverse studies on obesity have been published under the title of Journal of Korean Society for the Study of Obesity until 2004. Since 2017, volume 26, the title is now the Journal of Obesity & Metabolic Syndrome (pISSN 2508-6235, eISSN 2508-7576). The journal is published quarterly on March 30th, June 30th, September 30th and December 30th. The official title of the journal is now "Journal of Obesity & Metabolic Syndrome" and the abbreviated title is "J Obes Metab Syndr". Index words from medical subject headings (MeSH) list of Index Medicus are included in each article to facilitate article search. Some or all of the articles of this journal are included in the index of PubMed, PubMed Central, Scopus, Embase, DOAJ, Ebsco, KCI, KoreaMed, KoMCI, Science Central, Crossref Metadata Search, Google Scholar, and Emerging Sources Citation Index (ESCI).